Ropeginterferon alfa-2b Enrolling by Invitation Phase 2 Trials for Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04655092Extension Study After Completion of Phase 2 Study for P1101 With Polycythemia Vera (PV) Patients (Study A19-201)